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Englanniksi (in English): 
Kainate receptors are known to regulate neuronal function in the brain (Li, H., & Rogawski, M. A. (1998), Braga, M. F. et al. (2004), 
Lerma & Marques (2013), Carta, M (2014)). In the amygdala, they have been shown to affect synaptic transmission and plasticity, 
as well as glutamate and γ-aminobutyric acid (GABA) release (Li, H. et al. (2001). Braga, M. F. et al. (2003), Braga, M. F. et al. 
(2009), Aroniadou-Anderjaska, V. et al. (2012), Negrete‐Díaz, J. V. et al. (2012)), however, their role during development of the 
amygdala circuitry is not known. In the present study, we wished to understand how GluK1 kainate receptors regulate synaptic 
population activity and plasticity in the developing amygdala by using extracellular field recordings in P15-18 Wistar Han rat pup 
brain slices. Since field excitatory postsynaptic potentials (fEPSPs) are not commonly measured from the amygdala, we first 
sought to pharmacologically characterize the basic properties of the extracellular signal, recorded from the basolateral amygdala in 
response to stimulation of the external capsulae (EC). Having confirmed the validity of the fEPSP as a measure of postsynaptic 
population response, we were able to show that blocking GluK1 with (S)-1-(2-Amino-2-carboxyethyl)-3-(2-carboxy-5-
phenylthiophene-3-yl-methyl)-5-methylpyrimidine-2,4-dione (ACET), a selective GluK1 antagonist, had no effect on the fEPSP. 
Furthermore, activation of GluK1 with RS-2-amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl) propanoic acid (ATPA), a GluK1 agonist, 
reduced the amplitude of the fEPSP, without affecting its slope, suggesting an increase in inhibitory signaling within the network. 
Blocking GABAergic activity with GABAA- receptor antagonist picrotoxin significantly reduced the effects of ATPA. Additionally, the 
increase in inhibitory signaling due to the activation of GluK1 was confirmed with whole-cell voltage clamp, by measuring 
spontaneous inhibitory postsynaptic current (sIPSC) frequency. Activation of GluK1 heavily increased sIPSC frequency in the 
basolateral amygdala neurons. Finally, we were also able to show that activation of GluK1 with ATPA strongly attenuates LTP 
induction. These results show that GluK1 kainate receptors play a vital role in the modulation of synaptic transmission and 
plasticity in the developing amygdala. 
Suomeksi: 
Kainaattireseptorit säätelevät hermosolujen toimintaa aivoissa (Li, H., & Rogawski, M. A. (1998), Braga, M. F. et al. (2004), Lerma 
& Marques (2013), Carta, M (2014)). Mantelitumakkeessa näiden reseptorien on osoitettu vaikuttavan synaptiseen signalointiin ja 
plastisuuteen, sekä glutamaatin ja γ-aminobutyyrihapon (GABA) vapautumiseen synaptisesta päätteestä (Li, H. et al. (2001). 
Braga, M. F. et al. (2003), Braga, M. F. et al. (2009), Aroniadou-Anderjaska, V. et al. (2012), Negrete‐Díaz, J. V. et al. (2012)), 
mutta niiden vaikutusta mantelitumakkeen hermoverkkojen kehitykseen ei tunneta. Tässä tutkielamssa halusimme ymmärtää 
kuinka GluK1 kainaatti reseptorit säätelevät synaptista populaatio aktiivisuutta ja plastisuutta kehittyvässä mantelitumakkeessa, 
mittaamaalla solunulkoisia kenttäpotentiaaleja P15-18 ikäisten Wistar Han rottien aivoleikkeistä. Koska solunulkoisia 
kenttäpotentiaaleja ei usein mitata mantelitumakkeesta, määritimme mittaamamme kenttäpotentiaalin ominaisuudet 
farmakologisesti. Kun kenttäpotentiaalin validiteetti oli määritetty, kykenimme osoittamaan, että GluK1 kainaattireseptorien 
toiminnan esto S)-1-(2-Amino-2-karboxyethyyli)-3-(2-karboxy-5-fenyylithiofeny-3-yli-metyyli)-5-metyylipyrimidiini-2,4-dioni (ACET) 
ei aiheuttanut merkittäviä muutoksia kenttäpotentiaalissa. GluK1 aktivaatio GluK1 agonistilla RS-2-amino-3-(3-hydroxy-5-tert-
butylisoxazol-4-yl) proprionihappolla (ATPA) madalsi kenttäpotentiaalin amplitudia, vaikuttamatta sen konduktiojyrkkyyteen, viitaten 
inhibitorisen signaloinnin lisääntymiseen hermoverkossa. Estämällä GABAergiset reseptorit pikrotoksiinilla (GABAA-reseptori 
antagonisti) ATPAn vaikutukset kenttäpotentiaalin amplitudiin vähenivät merkittävästi. Lisäksi, varmistimme että GluK1 aktivointi 
ATPAlla lisää inhibitorista signalointia mantelitumakkeessa, mitaamalla spontaanin inhibitorisen signaloinnin frekvenssiä kokosolun 
virtalukituksella. GluK1 aktivaatio kasvatti spontaanin inhibitorisen signaloinnin frekvenssiä merkittävästi mantelitumakkeen 
neuroneissa. Lopuksi kykenimme myös osoittamaan, että GluK1 kainaattireseptorien aktivointi ATPAlla estää pitkäkestoisen 
potentiaation (LTPn) muodostumista. Tuloksemme osoittavat, että GluK1 reseptorit olennaisesti säätelevät synaptista signalointia 
ja plastisuuttaa kehittyvässä mantelitumakkeessa.        
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1. Abstract 
 
 
Kainate receptors are known to regulate neuronal function in the brain (Li, H., & Rogawski, M. A. 
(1998), Braga, M. F. et al. (2004), Lerma & Marques (2013), Carta, M (2014)). In the amygdala, 
they have been shown to affect synaptic transmission and plasticity, as well as glutamate and γ-
aminobutyric acid (GABA) release (Li, H. et al. (2001). Braga, M. F. et al. (2003), Braga, M. F. et 
al. (2009), Aroniadou-Anderjaska, V. et al. (2012), Negrete‐Díaz, J. V. et al. (2012)), however, their 
role during development of the amygdala circuitry is not known. In the present study, we wished to 
understand how GluK1 kainate receptors regulate synaptic population activity and plasticity in the 
developing amygdala by using extracellular field recordings in P15-18 Wistar Han rat pup brain 
slices. Since field excitatory postsynaptic potentials (fEPSPs) are not commonly measured from the 
amygdala, we first sought to pharmacologically characterize the basic properties of the extracellular 
signal, recorded from the basolateral amygdala in response to stimulation of the external capsulae 
(EC). Having confirmed the validity of the fEPSP as a measure of postsynaptic population response, 
we were able to show that blocking GluK1 with (S)-1-(2-Amino-2-carboxyethyl)-3-(2-carboxy-5-
phenylthiophene-3-yl-methyl)-5-methylpyrimidine-2,4-dione (ACET), a selective GluK1 
antagonist, had no effect on the fEPSP. Furthermore, activation of GluK1 with RS-2-amino-3-(3-
hydroxy-5-tert-butylisoxazol-4-yl) propanoic acid (ATPA), a GluK1 agonist, reduced the amplitude 
of the fEPSP, without affecting its slope, suggesting an increase in inhibitory signaling within the 
network. Blocking GABAergic activity with GABAA- receptor antagonist picrotoxin significantly 
reduced the effects of ATPA. Additionally, the increase in inhibitory signaling due to the activation 
of GluK1 was confirmed with whole-cell voltage clamp, by measuring spontaneous inhibitory 
postsynaptic current (sIPSC) frequency. Activation of GluK1 heavily increased sIPSC frequency in 
the basolateral amygdala neurons. Finally, we were also able to show that activation of GluK1 with 
ATPA strongly attenuates LTP induction. These results show that GluK1 kainate receptors play a 
vital role in the modulation of synaptic transmission and plasticity in the developing amygdala.  
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2. Introduction 
 
 
2.1 The Amygdala – Form and Function 
 
The amygdala is a teardrop-shaped structure residing within the lower parts of the temporal lobe. It 
is commonly divided in to the basolateral, cortical and centromedial nuclei and receives input 
mainly from the afferent cortical and thalamic projections (sensory and memory related 
information), as well as from hypothalamic and brainstem projections (behavioral information) (Sah 
et al. (2003)). We will mainly focus on the basolateral nuclei, which can be further divided in to the 
lateral (LA) and basolateral (BLA) parts. They receive glutamatergic inputs from the cortex via the 
external capsule (EC) and from the thalamus via the internal capsule (IC) (Mahanty, N. K., & Sah, 
P. (1999)). These glutamatergic projections innervate a morphologically and functionally diverse 
array of neurons. The most abundant type of neuron within the lateral and basolateral divisions of 
the amygdala are pyramidal neurons (~70%), followed by smaller and rounder, non-pyramidal 
stellate cells (Millhouse, O. E., & DeOlmos, J. (1983)), which were later identified as various types 
of GABAergic interneurons (McDonald, A. J. (1985), McDonald, A. J., & Pearson, J. C. (1989)).  
The amygdala plays an important role in emotional learning processes (LeDoux, J. (2003), 
McGaugh, J. L. (2004). It has been implicated in regulating fear conditioning and extinction 
memory, as well as anxiety and stress induced behaviors (Davis, M. (1992), Dityatev, A. E., & 
Bolshakov, V. Y. (2005), Roozendaal, B. et al. (2009)), through synaptic plasticity within the 
network (Fanselow, M. S., & LeDoux, J. E. (1999), Blair, H. T. et al. (2001), Dityatev, A. E., & 
Bolshakov, V. Y. (2005), Pape, H. C., & Pare, D. (2010)). Extensive research has gone in to 
uncovering the mechanisms that underlie fear-learning in the amygdala. Initial studies simply noted 
that lesions restricted to the amygdalar nuclei caused severe impairments in fear learning (LeDoux 
et al. (1990), LaBar, K. S., & LeDoux, J. E. (1996), Majidishad, P. et al. (1996), Goosens, K. A., & 
Maren, S. (2001)). In conjunction with these results, N-methyl-D-aspartate (NMDA) receptors were 
observed to be necessary for fear conditioning to take place (Maren, S., et al. (1996), Lee, Hongjoo 
J., et al. (2001), suggesting that NMDA receptor dependent long-term potentiation (LTP), a classic 
form of synaptic plasticity extensively studied in the hippocampus (Bliss, T. V., & Collingridge, G. 
L. (1993), Malenka, R. C. (1994), Tsien, J. Z et al (1996) Lu, W. Y. et al. (2001)),  could underlie 
learning in the amygdala. Indeed, Huang and Kandel (1998) showed that protein kinase A (PKA) 
dependent postsynaptic LTP, which was partially reliant on NMDA receptors, could be induced in 
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the LA when stimulating the EC. Furthermore, Rogan et al. (1997) showed that fear conditioning 
produced similar evoked responses in the lateral amygdala as LTP induction. Later investigations 
by Nabvi et al. (2014) showed strong supporting evidence that LTP in the amygdala is the 
underlying cause of fear memory, while long-term depression (LTD) can be used to suppress said 
memory.  
Additional forms of LTP exist in the amygdala. Interestingly, Weisskopf et al (1999) showed that 
LTP induced by stimulating the IC is NMDA receptor independent. Furthermore, other 
investigators have shown that cortical glutamatergic projections on to amygdalar interneurons 
exhibit an NMDA receptor independent form of LTP (Mahanty, N. K., & Sah, P. (1998)), whereas 
thalamic projections innervating GABAergic interneurons exhibit NMDA receptor dependent LTP 
(Bauer & LeDoux (2004)). More recent speculation has arisen that these forms of increased 
glutamatergic drive to interneurons underlie fear extinction learning (Maren, S. (2015)). The 
important point to keep in mind however, is simply the fact that complex and multiple forms of 
plasticity are present in the amygdala and these will become a point of consideration later on in the 
discussion of results. 
 
2.2. Kainate Receptors in the Amygdala 
 
Kainate receptors are non-NMDA-type glutamate receptors with both ionotropic and metabotropic 
modes of action, composed of tetrameric arrangements of GluK1-5 subunits. (Contractor, A. et al. 
(2011), Lerma & Marques (2013) Sihra, T. S. et al. (2014)). They are known to be widely expressed 
in both glutamatergic and GABAergic connections, in pre- and postsynaptic terminals, and they are 
known to modulate synaptic transmission and plasticity in the amygdala (Li, H. et al. (2001). Braga, 
M. F. et al. (2003), Braga, M. F. et al. (2009), Aroniadou-Anderjaska, V. et al. (2012), Negrete‐
Díaz, J. V. et al. (2012)).  
In particular, Li, H., & Rogawski, M. A. (1998) showed that GluK1 subunit containing kainate 
receptors mediate about 25-30% of the total excitatory glutamatergic drive to BLA principal 
neurons, thereby indicating their important role in the overall activity of the amygdala (see also: 
Cho et al. (2012)). Aroniadou-Anderjaska, V. et al. (2012) further proved that low concentrations of 
GluK1 agonist ATPA increases spontaneous excitatory postsynaptic current (sEPSC) and miniature 
excitatory postsynaptic current (mEPSC )frequency in BLA neurons and can lead to anxiogenic 
behavior. Additionally, Braga, M. F. et al. (2003) showed that GABA release is modulated by the 
7 
 
activation of presynaptic GluK1 in a concentration-dependent manner, elucidating that GluK1 also 
plays an important role in GABAergic signaling within the amygdala. Low concentrations of ATPA 
increased miniature inhibitory postsynaptic current (mIPSC) frequency while the converse 
happened with larger concentrations. Wu et al. (2007) also showed that activation of GluK1 
increases the excitability of GABAergic interneurons, while pyramidal neuron excitability is 
decreased.  
Considering the above results together, it is easily observable that GluK1 kainate receptors shape 
synaptic activity in the amygdala in complex ways, affecting both glutamatergic and GABAergic 
signaling. However, it is not known what the net result of these effects are on a synaptic population 
level. Furthermore, little is known about how kainate receptors modulate synaptic function at 
different developmental stages, knowing that the expression of various types of kainate receptors 
(especially GluK1) heavily changes during development (Bettler et al. 1990, Bahn et al. 1994). In 
the P15 to 22 age range GluK1 and GluK2 kainate receptors are strongly expressed in the amygdala 
(Braga et al. (2003)), indicating that they may play a significant role in the regulation of amygdalar 
networks during development. 
 
2.3. The Aims of This Study 
 
Kainate receptors exhibit a variety of effects on synaptic transmission in the amygdala, however, 
their functions during development of the circuitry are less well understood. The aim of this study 
was to investigate what the net effect of GluK1 kainate receptors on synaptic population activity 
and plasticity are in the developing amygdala of P15 to 18 rat pups. To do this, we used 
extracellular field recordings and studied how postsynaptic glutamatergic responses evoked by 
afferent stimulation (external capsulae (EC)) change under pharmacological manipulations of 
GluK1. We also used whole cell voltage clamp to further elucidate the effects of GluK1 on the 
single cell level. Finally, we investigated if LTP induction is possible in the 2-week-old amygdala 
and how plasticity is regulated by GluK1. 
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3. Materials and Methods 
 
 
3.1. Brief theory of extracellular field potentials and voltage clamp 
 
Extracellular field potentials are generated by charge movement across cell membranes during 
neuronal population activity. Charged ions (mainly Na+, K+, Ca2+ and Cl-) moving across cell 
membranes during synaptic activity create transmembrane currents that can be measured from the 
extracellular space (Leung, L. W. S. (1990)). To exemplify this, let’s consider a single pyramidal 
neuron, shown also in Figure 1. Activation of excitatory synaptic contacts in the dendritic tree cause 
an influx of positive ions in to the postsynaptic compartments. This will cause a positive current to 
flow in to the cell, momentarily leaving the extracellular negatively charged. If we were to place an 
electrode in the extracellular space near the dendritic tree during this conductive event, we would 
measure a negative voltage deflection (voltage being the product of current and resistance). This 
point in the extracellular space then becomes a current sink. 
The positive current flowing in to the postsynaptic compartments does not simply remain there but 
continues to flow through the resistive intracellular fluid towards the soma. Kirchhoff’s first law 
states that at any point in an electrical circuit, current inflow and outflow must sum to zero. This 
law is derived from the fundamental physical principle of charge conservation, which states that the 
amount of positive and negative charges in an isolated system is always conserved. This means that 
any charge flowing in to a given volume of space must be matched by an outflow of charge from 
that volume of space. Accordingly, positive current that rushed in at the distal dendrites, exits at the 
soma, creating a current source. Relative to the current sink - the point in the extracellular space that 
during this conductive event becomes negatively charged - the current source will be positively 
charged. Thus, if we were to place an electrode in the extracellular medium near the soma during 
this conductive event, we would observe a positive voltage deflection. 
The outflowing current at the current source then flows back through the resistive extracellular 
medium to the current sink, forming a closed electrical circuit. Kirchhoff’s second law states that 
that the sum of voltages in a closed loop in an electrical circuit must equal zero. This is derived not 
only from the principle of charge conservation is also related to even more fundamental principle of 
conservation of energy, without which physical phenomena as we know them would not be 
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possible. Hence, these considerations of Kirchhoff’s laws are not arbitrary but fundamental to 
understanding how electrical phenomena in the extracellular space take place.  
It should also be kept in mind that when discussing extracellular field potentials, we are always 
talking about the activity of hundreds or thousands of neurons, depending on where we place the 
recording electrode. Thus, the voltage deflections measured are the combinatory current sinks and 
sources generated by the simultaneous activity of many neurons. Figure 1C exemplifies current 
source and sink densities generated by a laminar array of neurons and this is commonly how 
extracellular field potentials measured from the hippocampus are theorized to be generated 
(Holsheimer, J. (1987)). However, due to the complex neuronal architecture of the amygdala, the 
neurons contributing to the measured signal become much more difficult to discern. This will 
become a point of consideration later on in the discussion.   
 
 
Figure 1.  
A) Current loop formed in a pyramidal neuron when excitation arrives at the distal dendrites.  
B) A more macroscopic view of the pyramidal neuron and the voltage deflection observed from the 
extracellular space. Placing the measurement electrode near the apical dendrites (current sink) 
during a conductive event will result in the measurement of a negative voltage deflection. 
Conversely, measuring from the somatic area (current source) will result in the measurement of a 
positive voltage deflection. 
C) Current sink and source densities created by a laminar array of neurons. 
 
In whole cell voltage clamp, currents flowing through the entire cell can be recorded, while 
controlling the membrane potential to a desired level. A patch glass microelectrode is placed on the 
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membrane of a cell and suction is applied. This allows the microelectrode to make tight contact 
with the membrane and form a giga-ohm seal or “gigaseal”. To enter the whole cell configuration, 
additional suction is applied to rupture the membrane, thus allowing the microelectrode to access 
the intracellular compartment 
To keep the membrane potential constant, the measurement system has to apply compensatory 
current when the membrane potential changes. Once the electrode detects a change in membrane 
potential due to ionic currents flowing across the membrane, this is fed to a feedback amplifier 
along with a voltage command signal. The command signal expresses the desired membrane 
potential which the experimenter wants to hold the cell at. If the changed membrane potential 
differs from the command signal, an error signal is sent through a current generator, which then 
sends a current back down to the cell to return the membrane potential back to the command value. 
It’s important to note that this injected current is the current that the voltage clamp system measures 
and that this injected current is equal to ionic currents mediated by ion channels on the cell 
membrane. This is because in order to keep the membrane potential constant, the injected current 
has to exactly match all ionic currents in the cell that attempt to change the membrane potential 
from the command value. As an example, let’s say that we are clamping the membrane potential at -
70 mV and at a certain point in time, cations flow in to the cell, causing membrane depolarization to 
-60 mV. The voltage clamp system measures this depolarization and injects a negative current in 
order to bring the membrane potential back down to – 70 mV. Hence, currents caused by cations 
that bring positive charge in to the cell, will be measured as negative current deflection, since the 
injected current is negative. Similarly, hyperpolarizing currents will be seen as positive current 
deflections, since the injected current to counteract membrane hyperpolarization from the command 
value will be positive.   
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Figure 2. A simplified schematic of single electrode whole cell voltage clamp. The microelectrode 
measures voltage changes across the membrane (Vm). This amplified signal travels to the feedback 
amplifier which compares Vm to the experimentally set holding voltage (Vcommand). If there is a 
difference between the two an error signal is sent to the current generator which produces a current 
that is then injected to the cell in order to keep the membrane potential at Vcommand.      
3.2. Experimental procedures 
 
Animals used and ethical statement. Wistar Han rat pups aged P15-P18, both sexes, were used in 
this study. The total number of animals in these experimental results is 25, one animal used per 
experiment. To minimize suffering during the decapitation procedure, animals are first anesthetized 
with isoflurane. Loss of consciousness is ensured by a lack of reaction to pain by strongly squeezing 
the tail with tweezers. Decapitation is done quickly to make sure the animal does not wake up or 
feel pain from the procedure. All experiments with animals were done in accordance with the 
University of Helsinki Animal Welfare Guidelines.  
Reagents. All pharmacological compounds used in this study were supplied by Tocris. The 
pharmacological agents used were selective GluK1 antagonist ACET (200nM), selective GluK1 
agonist ATPA (1 µM), AMPA/kainate receptor antagonist 6-Cyano-7-nitroquinoxaline-2,3-dione 
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(CNQX) (20 µM), sodium channel antagonist tetrodotoxin (TTX) (1 µM) and GABAA- receptor 
antagonist picrotoxin (PiTX) (100 µM). 
For electrophysiological recordings P15 to P18 rat pups were anesthetized with isoflurane and 
quickly decapitated. The brain was extracted and immediately placed in carbogenated (95% 
O2/5%CO2) ice-cold modified artificial cerebrospinal fluid (ACSF) containing (in mM): NaCl 124, 
KCl 3, NaH2PO4 1.25, MgSO4 11, NaHCO3 26, D-glucose 15, Ca2Cl 1. The cerebellum and a small 
part of the prefrontal cortex were trimmed off, the brain glued to a stage and transferred to a 
vibratome (Leica VT 1200S) to obtain 400 µm thick brain slices. Slices containing the amygdala 
were placed in to a slice holder in 37oC heat bath, with the holder containing standard ACSF with 2 
mM Ca2Cl and 1 mM MgSO4 Slices were incubated in the heat bath for 30-40 minutes and in room 
temperature for an additional 30 minutes. 
For extracellular field recordings the brain slices were transferred to a carbogenated and preheated 
interface recording chamber (32-33oC) and were perfused with prewarmed (34oC) ACSF with the 
speed of 1.25 ml/minute. To obtain stable local field potential (fEPSP) from the developing 
amygdalar circuit, the stimulation and recording electrodes had to be placed rather close to each 
other. Stimulation electrode was placed in to the EC containing cortical projection axon, very near 
the apical part of the amygdala, and the recording electrode was placed near the top of the lateral 
amygdala (LA). Recording electrode glass micropipette (Harvard Apparatus 1.5 OD x 0.56 ID x 
75L mm) resistance was around 3-5 MΩ and was filled with ACSF. In order to obtain stable 
recordings, slices were allowed to sit in the recording chamber for 15 – 30 minutes before the 
experiment was started. This helped attenuate drift in amplitude and/or slope. Recordings consisted 
of 15 minutes of baseline, after which a drug was added or LTP was induced using 100Hz/s 
stimulation, depending the experiment. During the experiments using picrotoxin, fEPSPs often 
became polysynaptic which made the measurement of fEPSP amplitudes difficult. If the amplitude 
did not remain stable after bath application of picrotoxin, the recording was disqualified. fEPSPs 
were amplified (Axon Instruments AxoPatch 200B, 100x gain), lowpass filtered (5 kHz), A/D 
converted (Axon Instruments Digidata 1322 16-bit data acquisition system, 20 kHz sampling 
frequency) and gathered/analyzed online and offline with WinLTP version 1.11. 
For whole cell voltage clamp experiments slice preparation was done using a sucrose-based 
dissection solution containing (in mM): NaCl 87, NaHCO3 25, KCl 2.5, NaH2PO4 1.25, MgSO4 7, 
Ca2Cl 0.5, D-glucose 25, sucrose 50. Slices were placed in a submerged heated (37
oC, Luigis and 
Neumann Badcontroller V) recording chamber and perfused with standard ACSF at the speed of 
1.25 ml/minute. LA neurons were patched using 5-7 MΩ glass electrode micropipettes, filled with a 
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potassium based low chloride filling solution containing (in mM): K-gluconate 135, HEPES 10, 
KCl 2, CaOH2 2, EGTA 2, Mg-ATP 4, Na-GTP 0.5. After obtaining a strong gigaseal, the cell 
membrane was ruptured to enter whole-cell configuration. The membrane potential was clamped at 
-70 mV, and the cell was allowed to equilibrate with the filling solution for 10 minutes. Afterwards 
the membrane potential was slowly raised to 0 mV, the reversal potential of glutamatergic currents, 
in order to only measure spontaneous inhibitory postsynaptic currents (sIPSC). The recording was 
once again allowed to stabilize for 5-10 minutes prior to baseline measurement. After baseline 
recordings (10 min), 1 µM ATPA was perfused in to the bath (15-20 min) and a rewash period was 
carried out for 20 minutes. The recorded signal was amplified (Axon Instruments Multiclamp 
700B), lowpass filtered (5 kHz), A/D converted (Axon Instruments digidata 1322 16-bit data 
acquisition system, 20 kHz sampling frequency) and gathered with WinLTP version 1.11. sIPSC 
frequency analysis was done manually using Minianalysis program 6.0.3. sIPSCs were identified in 
the analysis as outward currents with typical kinetics, that were at least 3 times the amplitude of the 
baseline level of noise. 
Statistical analysis. Averages and the standard error of mean (S.E.M.)s of the analyzed properties of 
synaptic events were calculated for baseline and drug/LTP condition, for repeated experiments. The 
latter averages were calculated 15 minutes after drug application and 50 minutes after 100Hz/s 
stimulation, respectively. When comparing two conditions within an experiment, two tailed t-test p-
values were calculated from raw data values. One-way ANOVA was used for statistical comparison 
when comparing between experimental groups. These are the statistical values presented throughout 
this paper. For graphical representation of measurements, fEPSP amplitude and slope were 
normalized to baseline, and these normalized values were averaged across measurements. The 
graphs represent averaged values, with error bars corresponding to S.E.M values. Statistical 
significance is denoted with * (p < 0.05)   
 
4. Results 
 
4.2. Pharmacological characterization of the amygdalar fEPSP 
 
First, we wanted to confirm that the synaptic origin of the extracellular signal, recorded from the 
lateral amygdala in response to EC stimulation in brain slices from juvenile (P15-18) rat pups. The 
measured signal consisted of two negative deflecting voltage peaks (First voltage peak amplitude: -
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-0.33 ± 0.03 mV, slope: -0.62 ± 0.04 mV/ms - Second voltage peak amplitude: -0.75 ± 0.02 mV, 
slope: -0.39 ± 0.02 mV/ms). To see if either of these were mediated by postsynaptic ionotropic 
glutamate receptors, we used CNQX (1 µM) to block postsynaptic AMPA/kainate receptors. This 
caused the second, larger voltage peak to disappear from the signal (Amplitude: 0.06 ± 0.02 mV, 
Slope: 0.14 ± 0.02 mV/ms), (Figure 3B, middle trace), indicating that the latter part of the signal 
reflected a field excitatory postsynaptic potential (fEPSP) (n = 5). Next, we used sodium channel 
blocker TTX (1 µM) in conjunction with CNQX (20 µM) to see if this would remove the remaining 
voltage peak (Amplitude: -0.31 ± 0.01 mV – Slope: -0.41 ± 0.05 mV/ms). Indeed, in the presence of 
TTX, the remaining part of the signal was eliminated, leaving only the stimulus artefact (Figure 3B, 
bottom trace) (n = 5). This indicated that this element of the signal was a presynaptic fiber volley, 
mediated by activation of axonal or presynaptic voltage-gated sodium channels.    
 
 
Figure 3.  
A) Coronal rat brain slice indicating the electrode positions for fEPSP recordings. Stimulation 
electrode is placed on the external capsule, near the apical part of the amygdala. Recording 
electrode is placed in the lateral amygdala (LA).  
B) Traces showing the basic pharmacological characterization of the fEPSP obtained from the LA. 
Top trace indicates baseline recording, showing voltage gated sodium channel mediated presynaptic 
fiber volley as a small negative deflection, followed by a larger negative deflection indicating 
postsynaptic sodium conductance through AMPA/KA receptors. Middle trace shows what happens 
to the fEPSP when AMPA/KA receptor antagonist CNQX (20µM) is used. The postsynaptic 
AMPA receptor mediated element is removed and only the presynaptic fiber volley remains. 
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Bottom trace shows the signal while perfusing CNQX and sodium channel blocker TTX (1µM) in 
to the brain slice. Only the stimulus artefact remains. 
 
4.3. ACET had no effect on the fEPSP 
 
After having confirmed pharmacologically that a postsynaptic glutamatergic field response (fEPSP) 
could be reliably evoked in response to EC stimulation in the juvenile amygdala, we next sought to 
test if GluK1 kainate receptor blocker ACET (200 nM) had any effects on the fEPSP. We observed 
no significant changes in fEPSP slope (fEPSP slope: 102.2 ± 3.5 % of baseline, n = 3, p = 0.61, 
Students two-tailed, paired t-test) or amplitude (fEPSP amplitude: 109 ± 5.9% of baseline, n = 3, p 
= 0.17, Students two-tailed, paired t-test) in response to application of ACET (Figure 4). 
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Figure 4.  
A) Example fEPSP traces from left to right: baseline, ACET, superimposed.  
B) A time-course plot representing the effects of ACET on fEPSP amplitude (n = 3). 
C) A time-course plot representing the effects of ACET on fEPSP slope (n = 3). 
D) Histogram showing the % of baseline of both slope and amplitude. 
 
 
4.4. Activation of GluK1 with ATPA increases GABAergic inhibition in 
the amygdala 
 
Seeing that blocking GluK1 kainate receptors with ACET produced no significant effect, we wanted 
to see whether the activation of GluK1 with ATPA (1 µM), a selective GluK1 agonist, would affect 
the fEPSP. Interestingly, the addition of ATPA reduced the peak amplitude of the fEPSP (fEPSP 
amplitude: 82.6 ± 3.5 % of baseline, n = 3, p = 0.001, Students two-tailed, paired t-test) but seemed 
to have no effect on the slope (fEPSP slope: 95.9 ± 7.8% of baseline, p = 0.52, Students two-tailed, 
paired t-test) (Figure 5A, B, C, D and E). 
This suggested to us that perhaps the activation of GluK1 is increasing GABAergic inhibition 
targeted at the synaptic population. To confirm this hypothesis, we tested whether or not ATPA 
would have a similar effect on the fEPSP amplitude, while blocking GABAA receptors with 
GABAA receptor antagonist picrotoxin (PiTX) (100 µM). Picrotoxin changed the shape and 
increased the amplitude (fEPSP amplitude: 134.6 ± 4.5 % of baseline, n = 3, p = 0.02, Students 
two-tailed, paired t-test) and the slope (fEPSP slope: 145 ± 12.8 % of baseline, n = 3, p = 0.02, 
Students two-tailed, paired t-test) of the fEPSP, also causing an increase in polysynaptic activity. 
Adding ATPA to the perfusion in the presence of PiTX caused a mild decrease in both the slope 
(fEPSP slope: 135.3 ± 13.6 % of baseline, n = 3, p = 0.05) and amplitude (fEPSP amplitude: 126.8 
± 3.9 % of baseline, n = 3, p = 0.02, Students two-tailed, paired t-test), as compared to the level in 
PiTX (Figure 5D, E, F, G, H and I). However, the effect of ATPA on fEPSP amplitude in the 
presence of PiTX was significantly smaller as compared to its effect under control conditions 
(fEPSP amplitude (PiTX + ATPA): 94.2 ± 1,4 % of 10 min stabilized PiTX region - fEPSP 
amplitude (ATPA): 82.6 ± 3.5 % of baseline, F (1,4) = 18.731; p = 0.012, One-way ANOVA). 
Additionally, drift or slice deterioration due to extensive picrotoxin use as the cause of the 
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amplitude reduction in the picrotoxin + ATPA experiments cannot be ruled out either with such a 
small sample size.  
To further ensure that inhibitory signaling is increased in the amygdala due to the activation of 
GluK1, we measured the effects of ATPA on sIPSC frequency in LA neurons using whole-cell 
voltage clamp. ATPA significantly increased sIPSC frequency in the amygdala (sIPSC 
frequency:3.88 ± 0.98x the baseline, n = 9, p = 0.007, Students two-tailed, paired t-test) but had no 
significant effects on sIPSC amplitude (sIPSC amplitude: 1.09 ± 0,04x baseline, n = 9, p = 0.32, 
Students two-tailed, paired t-test) (Figure 6 A, B and C). These results suggested to us that the 
activation of GluK1 causes an increase in spontaneous inhibition in the amygdala, thereby causing 
the reduction in fEPSP amplitude seen in the field potential recordings.  
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Figure 5.  
A) Example fEPSP traces from left to right: baseline, ATPA (1 µM), superimposed.  
B) Effects of ATPA on fEPSP amplitude (n = 3). Activation of GluK1 reduces fEPSP amplitude.  
C) Effects of ATPA of fEPSP slope (n = 3). Activation of GluK1 has seemingly no effects on 
fEPSP slope.  
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D) Example fEPSP traces from left to right: baseline, picrotoxin (100 µM), picrotoxin (100 µM) + 
ATPA (1 µM), superimposed.  
E) Effects of picrotoxin and ATPA on fEPSP amplitude (n = 3). Picrotoxin increases fEPSP 
amplitude and attenuates the effects of ATPA.  
F) Effects of picrotoxin and ATPA on fEPSP slope (n = 3).  
G) Pooled data showing the level of fEPSP amplitude and slope in the presence of drug 
perfusion(s). The data is expressed as % change compared to the baseline in the beginning of the 
experiment. 
H) A closer look at the fEPSP amplitude during the combined perfusion of ATPA and picrotoxin. 
Re-normalization of the data to the level in PiTX shows that activation of GluK1 in conjunction 
GABAA receptor blockade still causes a mild reduction in fEPSP amplitude 
I) Histogram depicting the effect of ATPA on fEPSP slopes and amplitudes under control 
conditions (ATPA) and in the presence of PiTX (ATPA + PiTX). The data is expressed as the % 
change compared to the level 0-10 min before ATPA application. Asterisk denotes a statistically 
significant difference in amplitudes (ATPA vs. PiTX + ATPA) (p = 0.012, One-way ANOVA).   
 
Figure 6.  
A) Example traces from sIPSC recordings in the amygdala. Top to bottom: baseline, ATPA (1 µM), 
rewash.  
B) Histogram showing the effects of ATPA on sIPSC frequency. Activation of GluK1 heavily 
increases sIPSC frequency (n = 9). Asterisk denotes statistical significance between baseline and 
ATPA (p = 0.007, Student’s two-tailed, paired t-test). 
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C) Histogram showing the effects of ATPA on sIPSC amplitude. 
 
4.5. Activation of GluK1 attenuates LTP induction 
 
Since plasticity in the amygdala is speculated as being the underlying mechanism for fear learning, 
we wanted to see if LTP induction was modulated by GluK1 activation. Using a 100Hz/s 
stimulation protocol a mild long term potentiation of fEPSPs could be induced in the amygdala 
(fEPSP slope: 131 ± 16 % of baseline, n = 7, p = 0.16, Students two-tailed, paired t-test - fEPSP 
amplitude: 109 ± 8.6 % of baseline, n = 7, p = 0.37, Students two-tailed, paired t-test) (Figure 7A, 
B, C, D and E). While there is an observable effect of the stimulation, this effect was not 
statistically significant. 
The activation of GluK1 by ATPA (1 µM) produced a similar reduction in amplitude as observed 
above and significantly attenuated LTP induction and, in fact, produced LTD when comparing the 
baseline to 50 minutes after 100Hz/s stimulation (fEPSP slope: 88.8 ± 12.9 % of baseline, n = 4, p 
= 0.47, Students two-tailed, paired t-test – fEPSP amplitude: 86.3 ± 3.2 % of baseline, n = 4, p = 
0.01, Students two-tailed, paired t-test). (Figure 7D, E, F and G). Comparing the level of synaptic 
potentiation, induced by 100Hz/s stimulation in the control conditions vs in the presence of ATPA 
gave statistically significant results (Slope ANOVA: F (1,9) = 7.138, p = 0.028 – Amplitude 
ANOVA: F (1,9) = 6.808 p = 0.031). This suggests that the increased inhibitory signaling in the 
amygdala due to the activation of GluK1 is strong enough to attenuate plasticity.  
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Figure 7.  
A) Example fEPSP traces from left to right: baseline, 60 min after 100Hz/s stimulation, 
superimposed.  
B) A time course plot illustrating the effects of 100Hz/s stimulation (marked with a red arrow) on 
fEPSP amplitude and slope (C) (n = 7).  
D) Example fEPSP traces from left to right: baseline, ATPA, ATPA + 60 min after 100Hz/s 
stimulation  
E) Effects of 100Hz/s stimulation on fEPSP amplitude, in conjunction with GluK1 kainate receptor 
activation (n = 4). The addition of ATPA causes a similar reduction in amplitude as shown in 
Figure 5B and blocks LTP induction. 
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F) Effects of 100Hz/s stimulation on fEPSP slope (n = 4), in conjunction with GluK1 kainate 
receptor activation. LTP induction is blocked due to the effects of ATPA.  
G) Pooled data comparing the effect of 100Hz/s stimulation on fEPSP slope and amplitude, under 
control conditions (n = 7) and in the presence of ATPA (n = 4). Asterisks denotes statistical 
significance in both slope (p = 0.028) and amplitude (p = 0.031) (One-way ANOVA). 
 
5. Discussion 
 
5.1. Methodological considerations 
 
Here, we were able to show that extracellular field potential recordings can provide information 
about how synaptic activity and plasticity are shaped by GluK1 subunit containing kainate receptors 
in the juvenile rat amygdala. However, it must be noted that due to the nature of these recordings, 
accurate mechanistic explanations for the effects remain elusive. The fEPSP shows the aftermath of 
various neuronal conductance events from the extracellular space. The sources and sinks that 
contribute to local field potentials are numerous beyond synaptic activity – fast action potentials, 
calcium spikes, intrinsic currents, varying afterhyperpolarizations of different types of neurons, gap 
junctions and ephaptic coupling (Buzsáki et al. 2016). Taking measurements from a developing 
synaptic population and knowing that the amygdala is intrinsically much more disorganized in its 
neuronal architecture, provided a challenge in discerning whether or not reliable postsynaptic field 
excitatory postsynaptic potentials (fEPSPs) could be obtained. Accordingly, we first sought to 
pharmacologically characterize the obtained extracellular signal, in order to be certain that we were 
measuring postsynaptic events. Having confirmed that the extracellular signal was indeed a 
glutamatergic fEPSP, we could then move on to study how inhibition and activation of GluK1 
affected the synaptic population activity and plasticity. 
It’s also important to note that wherever the measurement electrode is placed in the tissue, the 
resulting fEPSP is composed of all local neuronal and synaptic activity, including both excitatory 
and inhibitory signaling. In conjunction with this neuronal geometry and synaptic distribution has a 
strong effect on what kind of local field potential one can measure (Rall, W. (1962), Lindén et al. 
(2011), Buzsáki et al. (2016)). Combined with the considerations above, it’s easy to see how 
synaptic signaling can be masked by a plethora of effects when measuring extracellular signals. 
Hence, it would always be pertinent to combine extracellular recordings with intracellular ones, in 
order to truly unmask the effects any given treatment may have on synaptic signaling and plasticity. 
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A brief mention about statistics is in order. Most of the measurements done here had a very low n-
number. Despite the effects of a given treatment being very consistent, with low variability, in 
hindsight it would have been better to add a few more experiments to each test. One must also take 
note of the role of significance tests in scientific research. Statistical significance does not always 
equal to biological significance and vice versa. Hence, it is important to report both the effects and 
the statistical results as separate entities, and not outright dismiss a result if a clear effect can be 
seen but no statistical significance is obtained (Carver, R. (1978), Johnson, D. H. (1999), McShane, 
B. B. et al. (2017), Gigerenzer, G. (2018)).  
 
5.2. Blocking GluK1 had no effect on fEPSP 
 
Blocking GluK1 with ACET (200nM) had no significant effects on the fEPSP, evoked by EC 
stimulation in the lateral amygdala. However, this does not rule out the possibility that there may 
exist subtler effects on the neuronal level that are masked by the methodology used here. Indeed, 
Braga et al. (2009) have observed in slightly older animals (P18 to 24) that blocking GluK1 with 
topiramate leads to complex alterations of inhibitory and excitatory currents targeted to LA 
principal neurons. Blocking GluK1 seemed to reduce excitatory currents from glutamatergic 
afferents while simultaneously leading to the blocking of the suppression of inhibitory GABAergic 
signaling via inactivation of presynaptic GluK1 receptors on interneuron synaptic terminals - 
overall driving the amygdalar network towards increased inhibition. One must take note of the fact 
however, that topiramate is a non-selective antagonist for GluK1 and also attenuates voltage gated 
sodium channels (Zona et al (1997)), inhibits carbonic anhydrase isoenzymes (Dodgson et al. 
(2000)) and acts as an allosteric modulator of GABAA receptors (Simeone, T. A. et al (2006), 
Simeone, T. A et al. (2011). These effects may also contribute to their results, especially the 
GABAA receptor modulation. Aroniadou-Anderjaska, V. et al. (2012) et al. showed that GluK1 
antagonist UBP302 (25 µM) can reduce mEPSC frequency as well as reduce the amplitude of 
evoked field potentials and enhance their paired-pulse ratio. However, this was done in much older 
rats (35 to 50 day old). Since UBP 302 is a strongly selective GluK1 antagonist, it may be that the 
developmental stage of the amygdalar network contributes to these results. Similar results were 
produced by Cho et al. (2012), whom observed that UBP 302 reduces EPSC amplitude by roughly 
20 % in 3- to 4-week-old rats. 
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A future step for research could be to study the effects of ACET on EPSCs and IPSCs on the single 
cell level, to uncover whether or not some kind of refined dynamics exist and how these dynamics 
may change during development. Perhaps blocking GluK1 with ACET may also have some effects 
on LTP that were not explored in the present study.  
 
5.3. Activation of GluK1 with ATPA increases GABAergic inhibition in 
the amygdala 
 
Here, we were able to show that the activation of GluK1 kainate receptors increase GABAergic 
inhibition within the developing amygdala on both the synaptic population and single-cell levels. 
This is well in accordance with previous results obtained by other groups (Braga, M. F. et al. 
(2003), Aroniadou-Anderjaska, V. et al. (2007) Braga, M. F. et al. (2009)). Additionally, similar 
effects of GluK1 on GABA release and the activation of interneurons has been well documented in 
the hippocampus (Clarke, V. R., (1997). Cossart, R. et al. (1998), Cossart, R. et al. (2001), Jiang, L. 
et al. (2001), Jiang, L. et al. (2015)). Conversely, Li et al. (2001) showed that 20 µM ATPA could 
induce strong potentiation of excitatory postsynaptic potentials EPSP. Considering the high 
concentration used in conjunction with the results of Braga et al. (2003), whom show that high 
concentrations of ATPA (10 µM) cause a decrease in GABAergic inhibitory transmission targeted 
at BLA principal neurons, it seems likely that this is the reason why Li et al. (2001) observe a 
strong potentiation of the EPSP. We used a much lower concentration of ATPA (1 µM, specific 
concentration for GluK1 agonism), which in accordance with Braga et al. (2003) produces an 
increase in GABAergic transmission in the amygdala. 
Interestingly, our results further suggested that the increase in inhibitory signaling due to the 
activation of GluK1 is sufficient to block LTP induction in the lateral amygdala altogether. In 
accordance with the whole-cell voltage clamp measurements presented here, it does seem 
reasonable that such a heavy increase in inhibitory signaling targeted at the LA principal neurons 
would attenuate learning paradigms such as LTP. The fact that LA principal neurons are known to 
be heavily innervated by both parvalbumin and somatostatin interneurons (Muller, J. F. et al. 
(2006), Muller, J. F. et al. (2007)) and both of these interneuron types form local microcircuits that 
control fear learning (Ehrlich, I. (2009), Lucas, E. K. et al. (2016)), adds more confidence to the 
results obtained here. We hypothesize that the increased inhibition targeted at amygdala neurons 
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during GluK1 activation prevents strong membrane depolarization and thus NMDA receptor 
activation.  
When considering LTP induction in the control case, one must take note of the methodological 
limitations of the experiments done here once again. As discussed in the introduction, multiple 
forms of LTP exist in the amygdala that cause potentiation in both glutamatergic and GABAergic 
synapses (Huang & Kandel (1998), Mahanty, N. K., & Sah, P. (1998), Weisskopf et al (1999), 
Bauer & LeDoux (2004), Maren, S. (2015)). When using a strong stimulation protocol, such as the 
100Hz/s stimulation used here, a complex set of plasticity may occur within the synaptic 
population. Although masked by the limitations of extracellular field potentials, as discussed in 5.1, 
some speculation about the mechanisms and in particular, regarding the role of GluK1 in LTP 
induction can be made. Braga, M. F. et al. (2003) showed in P15 to 21 male Sprague Dawley rats 
GABAergic transmission targeted at pyramidal neurons in the amygdala is mediated by GluK1 
agonists in a concentration-dependent manner. Low concentrations of both ATPA and glutamate 
increased GABA release while high concentrations of these compounds had the opposite effect. 
Additionally, extracellular endogenous glutamate also increased the failure rates of evoked IPSCs 
(eIPSCs) but not sIPSCs. Taken together, they propose the idea that during strong stimulation, 
extracellular concentrations of glutamate become high enough to attenuate GABAergic 
transmission by acting on GluK1 kainate receptors on the presynaptic terminals of interneurons. 
Conversely, spontaneous activity would only produce low concentrations of extracellular glutamate, 
causing in increase in GABAergic transmission via the activation of somatodendritic GluK1 kainate 
receptors. Considering that in our field potential recordings we were able to observe a mild 
potentiation in response to strong afferent (EC) stimulation, in rat pups of a similar age, the 
mechanism proposed by Braga et al. (2003) could be at work here as well. While strong EC 
stimulation is activating both GABAergic and glutamatergic synapses, it seems that the net effect of 
this activity leads to LTP, perhaps permitted or facilitated by reduced GABAergic transmission via 
GluK1.    
A further approach could be to see how LTP is induced as such and under GluK1 manipulation on 
the single-cell level with whole cell voltage clamp. A simple pairing protocol coupling afferent 
stimulation to a brief membrane depolarization could potentially induce LTP and ATPA could 
easily be perfused in to the slice in order to see its’ effects. Additionally, if we wished to stick with 
field potential recordings, the ATPA + LTP experiments should also be carried out while blocking 
GABAA receptors with picrotoxin. This would show more clearly if a causal relationship exists 
between the increased inhibition caused by GluK1 activation and the attenuation of LTP induction. 
26 
 
It would also be interesting to observe how these dynamics between kainate receptors and 
GABAergic inhibitory signaling change during development, since this study is only limited to 
P15-18-time window.  
Some care must also be taken in interpreting the data where picrotoxin was used to block GABAA 
receptors in conjunction with ATPA. Picrotoxin has been shown to cause epileptic activity in the 
amygdala (Gean, P. W., & Shinnick-Gallagher, P. (1987)) and in our experiments, picrotoxin 
caused fEPSPs to become polysynaptic. This complicated the analysis of fEPSPs amplitudes, 
making them less reliable and stable due to polysynaptic noise. 
There is also the additional issue that picrotoxin did not fully seem to block the effects of ATPA. 
While the reduction in amplitude was much larger when perfusing ATPA alone as compared to the 
perfusion of ATPA with picrotoxin, some kind of effect still seems to be taking place. A simple 
explanation could be that extended use of picrotoxin eventually causes the slice to deteriorate, due 
to spontaneous firing activity (Gean, P. W., & Shinnick-Gallagher, P. (1987)). This would cause the 
amplitude as well as the slope to drift down, independent of ATPA application. Extending the 
recordings by an additional 15 minutes or simply doing more experiments to increase the n-number 
would have shown if this is the case.  
 
5.4. Concluding remarks 
 
Kainate receptors remain an important aspect in understanding the developing brain and they also 
play a vital role in health and disease (Lerma, J., & Marques, J. M. (2013)). Physiological roles of 
kainate receptors at immature neuronal networks have been mainly studied in the hippocampus 
(Lauri et. al (2005) (2006), Vesikansa et al. (2012)). However, their contribution in the development 
of amygdalar networks remains under investigation. Here, we were able to show within a restricted 
developmental time window that activation of GluK1 subunit containing kainate receptors regulates 
synaptic transmission and plasticity in the basolateral amygdala indirectly, via recruitment of 
GABAergic inhibition. Interestingly, Arora et al. (2018) have recently shown that GluK4 subunit 
containing kainate receptors in the amygdala play a significant role in behavior and 
neuropsychiatric disease. The results highlight the fact that we must also take in to account different 
isoforms of kainate receptors in the amygdala, if we wish to understand their role in development 
and disease. Hence, it remains pertinent that we continue our investigations of these tantalizing 
receptors in the future.  
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